Peripheral Arterial Insufficiency

Specialty Adblock test (Why?)

A cardiologist explains measures you can take to help prevent a heart attack caused by a major artery blockage. 7 Min Read • Heart Health • Story By Camille Bautista-Fryer

TOPLINE: Combined clopidogrel and aspirin initiated within 72 hours of a stroke is associated with a lower risk for a new stroke at 90 days but has a higher risk for moderate to severe bleeding than aspirin alone, new results of a randomized trial showed, suggesting treatment can be given past the current 24-hour time window for the use of dual antiplatelet therapy in patients with an ischemic stroke. METHODOLOGY: The analysis, part of the Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial, included 6100 patients, median age 65 years and 35.8% women, with a mild ischemic stroke, defined as a National Institutes of Health Stroke Scale (NIHSS) score ≤ 5, or a high-risk transient ischemic attack of presumed atherosclerotic origin, from 222 sites in China. Researchers randomly assigned patients within 72 hours of symptom onset to receive clopidogrel (300 mg on day 1 and 75 mg daily on days 2-90) plus aspirin (100-300

causes of peripheral vascular insufficiency :: Article Creator These Genetic Risk Loci Associated With Varicose Veins Have Been Identified By Researchers Varicose veins cause considerable suffering for more than cosmetic reasons. This disorder also poses health risks, sometimes severe ones. What is the most significant risk factor for varicose veins? What genetic risks do scientists associate with the disorder? Researchers now have more answers than ever. Recent investigations have identified several genetic risk loci that predispose a person to the disorder. Knowing your risk helps you take the appropriate steps to protect your health. What should you know if you have concerns? Here's what we know about the genes associated with varicose veins, the most significant risk factors and how you can reduce your chances of severe complications. What Are Varicose Veins? Symptoms and Causes

heart issues and symptoms :: Article Creator New Jersey Mom With Rare Heart Condition To Go Home To Her Son After Life-saving Transplant NEWARK, New Jersey -- The past year has been a nightmare for a first-time mother from New Jersey, who has had several heart-related emergencies after giving birth. But thanks to a life-saving heart transplant, she's finally going home to her son. Joseph Zion Griffith will celebrate his first birthday on February 1, and he will receive the best present he could ever have. His mom will finally be released from the hospital, for the first time in over two months! "It's been the hardest. He's so young," said heart transplant survivor Naiya Atkins. Atkins has been in Newark Beth Israel Medical Center's advanced heart failure treatment and transplant program's medical wing since November 30. She's a second-grade teacher and a new mom. Her doctor called her at work that day

vcu cardiology :: Article Creator UB Faculty Member To Receive The 2024 Dr. Carolyn McCue Award For Woman Cardiologist Of The Year BUFFALO, N.Y. – Anne B. Curtis, MD, SUNY Distinguished Professor in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, has been chosen to receive the 2024 Dr. Carolyn McCue Award for Woman Cardiologist of the Year. Curtis will be presented with the award at the Heart Health in Women Symposium that will be hosted in Richmond by the Virginia Commonwealth University Health Pauley Heart Center on Saturday, Feb. 3. Funded by a grant from the McCue family, the McCue Award honors the late Carolyn Moore McCue, MD (1916-1999), one of the few female cardiologists of her time, who served as the first woman elected president of the Richmond Academy of Medicine. During her 42 years of medical practice at the Medical College of Virginia (MCV, now VCU Health), she also

severe triple vessel disease :: Article Creator Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Coronary artery disease may not need to be treated before dealing with symptomatic severe aortic stenosis (AS), data from a single, high-volume medical center suggest. In a series of nearly 2,000 patients, there were no differences in all-cause mortality or major adverse cardiovascular events between those with coronary artery disease, even those with high- and extreme-risk obstructive disease, and those without coronary lesions. "We've been doing this diligently now for a number of years," senior investigator Rishi Puri, MD, PhD (Cleveland Clinic, OH), told TCTMD. "In our experience, these patients do very well with TAVR first as it then allows you to tackle the coronary disease in good time in a stable, controlled fashion." Puri said that their analysis, which was published last week in the Europea